Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Neuroradiology
Published in: Clinical Neuroradiology 1/2013

01-03-2013 | Original Article

An Evaluation of Subacute Sclerosing Panencephalitis Patients with Diffusion-Weighted Magnetic Resonance Imaging

Authors: M. Abuhandan, H. Cece, M. Calik, E. Karakas, F. Dogan, O. Karakas

Published in: Clinical Neuroradiology | Issue 1/2013

Login to get access

Abstract

Purpose

This study aimed to evaluate the contribution of diffusion weighted magnetic resonance imaging to the diagnosis and staging of subacute sclerosing panencephalitis.

Material and Method

The study comprised 26 patients diagnosed with subacute sclerosing panencephalitis at our clinic who were undergoing regular follow-up, and a control group of 18 subjects. Clinical staging was determined by Risk and Haddad classification; 12 at Stage II and 14 at Stage III. Diffusion weighted magnetic resonance images were taken of six areas (frontal, parieto-occipital, cerebellar, deep white matter, thalamus and basal ganglia) and by calculating the apparent diffusion coefficient (ADC) values, and a comparison was made between the stages and with the control group.

Results

The ADC values of all the areas of the subacute sclerosing panencephalitis patients were found to be significantly higher compared to the control group (p < 0.05). While the mean ADC values of the deep white matter, basal ganglia, frontal and parieto-occipital areas of the Stage II patients were found to be significant compared to the control group (p < 0.05), there was no significance in the other areas (p > 0.05). The ADC values of all the areas of the Stage III patients were found to be significantly high compared to the Stage II values (p < 0.05).

Conclusion

Diffusion weighted magnetic resonance imaging can be used with other diagnostic criteria to confirm diagnosis of subacute sclerosing panencephalitis and to reveal differences between the stages.
Literature
1.
Kobayashi N. Support system for families with sick children who need medical care at home. No To Hattatsu. 1996;28(3):231–35.PubMed
2.
Sawaishi Y, Yano T, Watanabe Y, Takada G. Migratory basal ganglia lesions in subacute sclerosing panencephalitis (SSPE): clinical implications of axonal spread. J Neurol Sci. 1999;168(2):137–40.PubMedCrossRef
3.
Onal AE, Gurses C, Direskeneli GS, Yilmaz G, Demirbilek V, Yentur SP, et al. Subacute sclerosing panencephalitis surveillance study in Istanbul. Brain Dev. 2006;28(3):183–9.PubMedCrossRef
4.
Anlar B, Pinar A, Yaşar Anlar F, Engin D, Ustaçelebi S, Kocagöz T, et al. Viral studies in the cerebrospinal fluid in subacute sclerosing panencephalitis. J Infect. 2002;44(3):176–80.PubMedCrossRef
5.
Risk WS, Haddad FS, Chemali R. Substantial spontaneous long-term improvement in subacute sclerosing panencephalitis. Six cases from the Middle East and a review of the literature. Arch Neurol. 1978;35(8):494–502.PubMedCrossRef
6.
Hamilton RL, Wiley CA. Neuropathology of viral infections of the nervous system (Ch 17). In: Davis RL, Robertson DM, editors. Textbook of Neuropathology. 3rd ed. Baltimore: William-Wilkins; 1997. pp. 984–88.
7.
Zilber N, Kahana E. Environmental risk factors for subacute sclerosing panencephalitis (SSPE). Acta Neurol Scand. 1998;98(1):49–54.PubMedCrossRef
8.
Dimova P, Bojinova V. Subacute sclerosing panencephalitis with atypical onset: clinical, computed tomographic, and magnetic resonance imaging correlations. J Child Neurol. 2000;15(4):258–60.PubMedCrossRef
9.
Yazaki M, Yamazaki M, Urasawa N, Morita H, Ikeda S. Successful treatment with alpha-interferon of a patient with chronic measles infection of the brain and parkinsonism. Eur Neurol. 2000;44(3):184–6.PubMedCrossRef
10.
Dyken PR, Maertens P. Viral Infections. In: Duckett S, editor. Pediatric Neuropathology. Baltimore: Williams-Wilkins; 1995;403–422.
11.
Alkan A, Korkmaz L, Sigirci A, Kutlu R, Yakinci C, Erdem G, et al. Subacute sclerosing panencephaitis: relationship between clinical satage and diffusion-weighted imaging findings. J Magn Reson Imaging. 2006;23(3):267–72.PubMedCrossRef
12.
Aydin K, Tatli B, Ozkan M, Ciftci K, Unal Z, Sani S, et al. Quantification of neurometabolites in subacute sclerosing panencephalitis by 1H-MRS. Neurology. 2006;67(5):911–3.PubMedCrossRef
13.
Caramia F, Pantano P, Di Legge S, Piattella MC, Lenzi D, Paolillo A, et al. A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis. Magn Reson Imaging. 2002;20(5):383–8.PubMedCrossRef
14.
Dyken PR. Subacute sclerosing panencephalitis: current status. Neurol Clin. 1985;3(1):179–96.PubMed
15.
Sener RN. Subacute sclerosing panencephalitis findings at MR imaging, diffusion MR imaging and proton MR spectroscopy. AJNR Am J Neuroradiol. 2004;25(5):892–94.PubMed
16.
17.
Oksuzler YF, Cakmakci H, Kurul S, Oksuzler M, Dirik E. Diagnostic value of diffusion-weighted magnetic resonance imaging in pediatric cerebral diseases. Pediatr Neurol. 2005;32(5):325–33.PubMedCrossRef
18.
Le Bihan D, Turner R, Douek P, Patronas N. Diffusion MR imaging: clinical applications. AJR Am J Roentgenol. 1992;159(3):591–99.CrossRef
19.
Hagmann P, Jonasson L, Maeder P, Thiran JP, Wedeen VJ, Meuli R. Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics. 2006;26(supp 1):s205–223.CrossRef
20.
Tsuchiya K, Yamauchi T, Furui S, Suda Y, Takenaka E. MR imaging vs CT in subacute sclerosing panencephalitis. AJNR Am J Neuroradiol. 1988;9(5):943–46.PubMed
21.
Le Bihan D. Molecular diffusion nuclear magnetic resonance imaging. Magn Reson Q. 1991;7(1):1–30.PubMed
22.
Frisoni GB, Testa C, Zorzan A, Sabattoli F, Beltramello A, Soininen H, Laakso MP. Detection of grey matter loss in mild Alzheimer’s disease with voxel based morphometry. J Neurol Neurosurg Psychiatry. 2002;73(6):657–64.PubMedCrossRef
Metadata
Title
An Evaluation of Subacute Sclerosing Panencephalitis Patients with Diffusion-Weighted Magnetic Resonance Imaging
Authors
M. Abuhandan
H. Cece
M. Calik
E. Karakas
F. Dogan
O. Karakas
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
Clinical Neuroradiology / Issue 1/2013
Print ISSN: 1869-1439
Electronic ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-012-0163-0

Other articles of this Issue 1/2013

Clinical Neuroradiology 1/2013 Go to the issue

Editorial

IMS-3, SYNTHESIS, and MR RESCUE: No Disaster, but Down to Earth

Review article

Solitary Spinal Extradural Plasmacytoma: A Case Report and Literature Review

Correspondence

Atretic Cephalocele and Associated Anomalies in a Newborn Child

Correspondence

Selective Injury of the Globus Pallidus and Hippocampus in Methamphetamine-Induced Encephalopathy

Correspondence

Cervical Artery Dissection in a Young Patient with Rubinstein-Taybi Syndrome

Correspondence

Bilateral Persistent Primitive Trigeminal Arteries Associated with Trigeminal Neuralgia